Aptevo Therapeutics (AP80.F) Q2 2025 Earnings

15MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-19.53
-14.27
-9.02
-3.76

Details

Expected EPS
-3.7619718
Actual EPS
-3.9228161999999998
Surprise EPS
-0.16
Surprise Percent
+4.28%

Description

Aptevo Therapeutics (AP80.F) has reported earnings of -3.9228161999999998 per share for Q2 2025.

0 Comments

Share your thoughts